The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Prevention or Amelioration of Autism-Like Symptoms in Animal Models: Will it Bring Us Closer to Treating Human ASD?
Abstract
Since the first animal model of valproic acid (VPA) induced autistic-like behavior, many genetic and non-genetic experimental animal models for Autism Spectrum Disorder (ASD) have been described. The more common non-genetic animal models induce ASD in rats and mice by infection/inflammation or the prenatal or early postnatal administration of VPA. Through the establishment of these models, attempts have been made to ameliorate or even prevent ASD-like symptoms. Some of the genetic models have been successfully treated by genetic manipulations or the manipulation of neurotransmission. Different antioxidants have been used (i.e., astaxanthin, green tea, piperine) to reduce brain oxidative stress in VPA-induced ASD models. Agents affecting brain neurotransmitters (donepezil, agmatine, agomelatine, memantine, oxytocin) also successfully reduced ASD-like symptoms. However, complete prevention of the development of symptoms was achieved only rarely. In our recent study, we treated mouse offspring exposed on postnatal day four to VPA with S-adenosine methionine (SAM) for three days, and prevented ASD-like behavior, brain oxidative stress, and the changes in gene expression induced by VPA. In this review, we describe, in addition to our data, the existing literature on the prevention/amelioration of ASD-like symptoms. We also discuss the possible mechanisms underlying some of these phenomena. Finally, we describe some of the clinical trials in children with ASD that were carried out as a result of data from animal studies, especially those with polyunsaturated fatty acids (PUFAs).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“During pregnancy and early post-natal life, exposure to VPA is associated with impaired behaviors as manifested by different behavioral tests [39].”
From Animal Models of Autistic-like Behavior in Rodents: A Scoping Review and Call for a Comprehensive Scoring System (2024) · cites this paper as [39]
In the citing paper
“Maternal immune activation (MIA), or activation of the maternal immune system by inflammation processes, is thought to play a significant role in the development of autism [39,50,51,52].”
From Animal Models of Autistic-like Behavior in Rodents: A Scoping Review and Call for a Comprehensive Scoring System (2024) · cites this paper as [39]
In the citing paper
“It stands out as one of the most used animal models due to its natural traits of the core autism symptom for investigating idiopathic ASD and have good face and construct validity [39,127,128,180,181,182].”
From Animal Models of Autistic-like Behavior in Rodents: A Scoping Review and Call for a Comprehensive Scoring System (2024) · cites this paper as [39]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The novel object recognition memory: neurobiology, test procedure, and its modifications
Antunes, M., & Biala, G. (2012) · Cognitive Processing · doi:10.1007/s10339-011-0430-z · Cited by 2,390 · cited 1×
“The time spent exploring novel and familiar objects and the discrimination index percentages are recorded [71,72].”
BackgroundBehavioural phenotyping assays for mouse models of autism
Silverman, J. L., Yang, M., Lord, C., & Crawley, J. N. (2010) · Nature Reviews Neuroscience · doi:10.1038/nrn2851 · Cited by 1,462 · cited 1×
“The test is based on measures of free interaction between the exposed and the control animal [59,65].”
BackgroundPrenatal Valproate Exposure and Risk of Autism Spectrum Disorders and Childhood Autism
Christensen, J., Grønborg, T. K., Sørensen, M. J., Schendel, D., Parner, E. T., Pedersen, L. H., & Vestergaard, M. (2013) · JAMA · doi:10.1001/jama.2013.2270 · Cited by 1,357
Reversal of Neurological Defects in a Mouse Model of Rett Syndrome
Guy, J., Gan, J., Selfridge, J., Cobb, S., & Bird, A. (2007) · Science · doi:10.1126/science.1138389 · Cited by 1,230 · cited 1×
“[8] postulated that in mice with Rett syndrome, the neurons do not die in spite of the MECP2 mutation, and that manipulation with the MECP2 gene might reverse the situation.”
BackgroundThe maternal interleukin-17a pathway in mice promotes autism-like phenotypes in offspring
Choi, G. B., Yim, Y. S., Wong, H., Kim, S., Kim, H., Kim, S. V., Hoeffer, C. A., Littman, D. R., & Huh, J. R. (2016) · Science · doi:10.1126/science.aad0314 · Cited by 1,214 · cited 1×
“[30] found that maternal immune activation in mice affected fetal cerebral cortical development, inducing autistic-like behavior.”
BackgroundBehavioral Alterations in Rats Prenatally Exposed to Valproic Acid: Animal Model of Autism
Schneider, T., & Przewłocki, R. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300518 · Cited by 959
Mouse behavioral tasks relevant to autism: Phenotypes of 10 inbred strains
MOY, S., NADLER, J., YOUNG, N., PEREZ, A., HOLLOWAY, L., BARBARO, R., BARBARO, J., WILSON, L., THREADGILL, D., & LAUDER, J. (2007) · Behavioural Brain Research · doi:10.1016/j.bbr.2006.07.030 · Cited by 776
Immune involvement in schizophrenia and autism: Etiology, pathology and animal models
Patterson, P. H. (2009) · Behavioural Brain Research · doi:10.1016/j.bbr.2008.12.016 · Cited by 766
Boksa, P. (2010) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2010.03.005 · Cited by 603 · cited 1×
“Studies have shown [23] that maternal immune activation induced changes in several interleukins in the fetal brain, as well as morphological changes in the hippocampus and cerebral cortex.”
BackgroundA clinical study of 57 children with fetal anticonvulsant syndromes
Moore, S. J., Turnpenny, P., Quinn, A., Glover, S., Lloyd, D. J., Montgomery, T., & Dean, J. C. S. (2000) · Journal of Medical Genetics · doi:10.1136/jmg.37.7.489 · Cited by 562
Research works printed but not linked: 60
- Baio, 2018, Prevalence of Autism Spectrum Disorder among Children Aged 8 Years—Autism and Developmental Disabilities Monitoring Network, 11 Sites, United States, 2014, MMWR Surveill. Summ., 67, 1, 10.15585/mmwr.ss6706a1 · DOI · Paper page
- Ergaz, 2016, Genetic and non-genetic animal models for autism spectrum disorders (ASD), Reprod. Toxicol., 64, 116, 10.1016/j.reprotox.2016.04.024 · DOI · Paper page
- Samaco, 2013, Female Mecp2(+/−) mice display robust behavioral deficits on two different genetic backgrounds providing a framework for pre-clinical studies, Hum. Mol. Genet., 22, 96, 10.1093/hmg/dds406 · DOI · Paper page
- Meyza, 2017, The BTBR mouse model of idiopathic autism—Current view on mechanisms, Neurosci. Biobehav. Rev., 76, 99, 10.1016/j.neubiorev.2016.12.037 · DOI · Paper page
- Oddi, 2015, Early social enrichment rescues adult behavioral and brain abnormalities in a mouse model of fragile X syndrome, Neuropsychopharmacology, 40, 1113, 10.1038/npp.2014.291 · DOI
- Lee, 2015, Is Oxytocin Application for Autism Spectrum Disorder Evidence-Based?, Exp. Neurobiol., 24, 312, 10.5607/en.2015.24.4.312 · DOI
- Zhang, 2017, The Role of the Oxytocin/Arginine Vasopressin System in Animal Models of Autism Spectrum Disorder, Adv. Anat. Embryol. Cell Biol., 224, 135, 10.1007/978-3-319-52498-6_8 · DOI
- Wagner, 2018, Oxytocin and Animal Models for Autism Spectrum Disorder, Curr. Top. Behav. Neurosci., 35, 213, 10.1007/7854_2017_15 · DOI
- Teng, 2016, Reversal of social deficits by subchronic oxytocin in two autism mouse models, Neuropharmacology, 105, 61, 10.1016/j.neuropharm.2015.12.025 · DOI
- Steinmetz, 2018, Insulin-Like Growth Factor II Targets the mTOR Pathway to Reverse Autism-Like Phenotypes in Mice, J. Neurosci., 38, 1015, 10.1523/JNEUROSCI.2010-17.2017 · DOI
- Yoshimura, 2017, Allosteric modulation of nicotinic and GABAA receptor subtypes differentially modify autism-like behaviors in the BTBR mouse model, Neuropharmacology, 126, 38, 10.1016/j.neuropharm.2017.08.029 · DOI
- Schwartzer, 2017, C57BL/6J bone marrow transplant increases sociability in BTBR T(+) Itpr3(tf)/J mice, Brain Behav. Immun., 59, 55, 10.1016/j.bbi.2016.05.019 · DOI
- Ornoy, A., Weinstein-Fudim, L., Tfilin, M., Ergaz, Z., Yanai, J., Szyf, M., and Turgeman, G. (2018). S-adenosyl methionine prevents ASD like behaviors triggered by early postnatal valproic acid exposure in very young mice. Neurotoxicol. Teratol. · DOI · Paper page
- Carpentier, 2011, Placental TNF-alpha signaling in illness-induced complications of pregnancy, Am. J. Pathol., 178, 2802, 10.1016/j.ajpath.2011.02.042 · DOI
- Ohkawara, 2015, Maternal viral infection during pregnancy impairs development of fetal serotonergic neurons, Brain Dev., 37, 88, 10.1016/j.braindev.2014.03.007 · DOI
- Xuan, I.C., and Hampson, D.R. (2014). Gender-dependent effects of maternal immune activation on the behavior of mouse offspring. PLoS ONE, 9. · DOI
- Lancaster, 2007, Abnormal social behaviors in young and adult rats neonatally infected with Borna disease virus, Behav. Brain Res., 176, 141, 10.1016/j.bbr.2006.06.013 · DOI
- Kirsten, T.B., Casarin, R.C., Bernardi, M.M., and Felicio, L.F. (2018). Pioglitazone abolishes autistic-like behaviors via the IL-6 pathway. PLoS ONE, 13. · DOI
- Vuillermot, 2017, Vitamin D treatment during pregnancy prevents autism-related phenotypes in a mouse model of maternal immune activation, Mol. Autism, 8, 9, 10.1186/s13229-017-0125-0 · DOI
- Christianson, 1994, Fetal valproate syndrome: Clinical and neuro-developmental features in two sibling pairs, Dev. Med. Child Neurol., 36, 361, 10.1111/j.1469-8749.1994.tb11858.x · DOI · Paper page
- Williams, 2001, Fetal valproate syndrome and autism: Additional evidence of an association, Dev. Med. Child Neurol., 43, 202, 10.1111/j.1469-8749.2001.tb00188.x · DOI · Paper page
- Bromley, 2008, Autism spectrum disorders following in utero exposure to antiepileptic drugs, Neurology, 71, 1923, 10.1212/01.wnl.0000339399.64213.1a · DOI · Paper page
- Wagner, 2006, A new neurobehavioral model of autism in mice: Pre- and postnatal exposure to sodium valproate, J. Autism Dev. Disord., 36, 779, 10.1007/s10803-006-0117-y · DOI · Paper page
- Rodier, 1997, Linking etiologies in humans and animal models: Studies of autism, Reprod. Toxicol., 11, 417, 10.1016/S0890-6238(97)80001-U · DOI · Paper page
- Banji, 2011, Amelioration of behavioral aberrations and oxidative markers by green tea extract in valproate induced autism in animals, Brain Res., 1410, 141, 10.1016/j.brainres.2011.06.063 · DOI
- Rahman, 2015, Astaxanthin improves behavioral disorder and oxidative stress in prenatal valproic acid-induced mice model of autism, Behav. Brain Res., 286, 112, 10.1016/j.bbr.2015.02.041 · DOI
- Pragnya, 2014, Ameliorating effect of piperine on behavioral abnormalities and oxidative markers in sodium valproate induced autism in BALB/C mice, Behav. Brain Res., 270, 86, 10.1016/j.bbr.2014.04.045 · DOI
- Yadav, 2017, Comparative efficacy of alpha-linolenic acid and gamma-linolenic acid to attenuate valproic acid-induced autism-like features, J. Physiol. Biochem., 73, 187, 10.1007/s13105-016-0532-2 · DOI
- Kumar, 2015, Benefits of agomelatine in behavioral, neurochemical and blood brain barrier alterations in prenatal valproic acid induced autism spectrum disorder, Neurochem. Int., 91, 34, 10.1016/j.neuint.2015.10.007 · DOI
- Kumar, 2016, Minocycline ameliorates prenatal valproic acid induced autistic behaviour, biochemistry and blood brain barrier impairments in rats, Brain Res., 1630, 83, 10.1016/j.brainres.2015.10.052 · DOI
- Kumar, 2016, Memantine ameliorates autistic behavior, biochemistry & blood brain barrier impairments in rats, Brain Res. Bull., 124, 27, 10.1016/j.brainresbull.2016.03.013 · DOI
- Kim, J.W., Seung, H., Kwon, K.J., Ko, M.J., Lee, E.J., Oh, H.A., Choi, C.S., Kim, K.C., Gonzales, E.L., and You, J.S. (2014). Subchronic treatment of donepezil rescues impaired social, hyperactive, and stereotypic behavior in valproic acid-induced animal model of autism. PLoS ONE, 9. · DOI
- Hara, 2015, Reduced prefrontal dopaminergic activity in valproic acid-treated mouse autism model, Behav. Brain Res., 289, 39, 10.1016/j.bbr.2015.04.022 · DOI
- Dai, 2018, Neonatal Oxytocin Treatment Ameliorates Autistic-Like Behaviors and Oxytocin Deficiency in Valproic Acid-Induced Rat Model of Autism, Front. Cell. Neurosci., 12, 355, 10.3389/fncel.2018.00355 · DOI
- Ha, 2017, Human adipose-derived stem cells ameliorate repetitive behavior, social deficit and anxiety in a VPA-induced autism mouse model, Behav. Brain Res., 317, 479, 10.1016/j.bbr.2016.10.004 · DOI
- Ornoy, 2018, Gender differences in the expression of nervous system genes in a mouse model of valproic acid-induced autism-like behavior is corrected by S-adenosyl methionine, Birth Defects Res., 11, 791
- Bjork, 2018, Association of Folic Acid Supplementation During Pregnancy with the Risk of Autistic Traits in Children Exposed to Antiepileptic Drugs In Utero, JAMA Neurol., 75, 160, 10.1001/jamaneurol.2017.3897 · DOI · Paper page
- Hara, 2016, Improvement by methylphenidate and atomoxetine of social interaction deficits and recognition memory impairment in a mouse model of valproic acid-induced autism, Autism Res., 9, 926, 10.1002/aur.1596 · DOI
- Segal-Gavish, H., Karvat, G., Barak, N., Barzilay, R., Ganz, J., Edry, L., Aharony, I., Offen, D., and Kimchi, T. (2015). Mesenchymal Stem Cell Transplantation Promotes Neurogenesis and Ameliorates Autism Related Behaviors in BTBR Mice. Autism Res. Off. J. Int. Soc. Autism Res. · DOI
- Seibenhener, M.L., and Wooten, M.C. (2015). Use of the Open Field Maze to measure locomotor and anxiety-like behavior in mice. J. Vis. Exp., e52434. · DOI · Paper page
- Basso, 1995, A sensitive and reliable locomotor rating scale for open field testing in rats, J. Neurotrauma, 12, 1, 10.1089/neu.1995.12.1 · DOI · Paper page
- Kuniishi, 2017, Early deprivation increases high-leaning behavior, a novel anxiety-like behavior, in the open field test in rats, Neurosci. Res., 123, 27, 10.1016/j.neures.2017.04.012 · DOI
- Crawley, 2004, Designing mouse behavioral tasks relevant to autistic-like behaviors, Ment. Retard. Dev. Disabil. Res. Rev., 10, 248, 10.1002/mrdd.20039 · DOI · Paper page
- Kaidanovich-Beilin, O., Lipina, T., Vukobradovic, I., Roder, J., and Woodgett, J.R. (2011). Assessment of social interaction behaviors. J. Vis. Exp., 2473. · DOI · Paper page
- Komada, M., Takao, K., and Miyakawa, T. (2008). Elevated plus maze for mice. J. Vis. Exp., 1088. · DOI · Paper page
- Deacon, 2006, T-maze alternation in the rodent, Nat. Protoc., 1, 7, 10.1038/nprot.2006.2 · DOI · Paper page
- Hamisha, 2015, Mesenchymal stem cells can prevent alterations in behavior and neurogenesis induced by Ass25–35 administration, J. Mol. Neurosci., 55, 1006, 10.1007/s12031-014-0457-6 · DOI
- Guariglia, 2013, Water T-maze: A useful assay for determination of repetitive behaviors in mice, J. Neurosci. Methods, 220, 24, 10.1016/j.jneumeth.2013.08.019 · DOI
- Leger, 2013, Object recognition test in mice, Nat. Protoc., 8, 2531, 10.1038/nprot.2013.155 · DOI · Paper page
- Sestakova, 2013, Determination of motor activity and anxiety-related behaviour in rodents: Methodological aspects and role of nitric oxide, Interdiscip. Toxicol., 6, 126, 10.2478/intox-2013-0020 · DOI · Paper page
- Buccafusco, J.J. (2009). Anxiety-Related Behaviors in Mice. Methods of Behavior Analysis in Neuroscience, CRC Press/Taylor & Francis. [2nd ed.].
- Hamm, 1994, The rotarod test: An evaluation of its effectiveness in assessing motor deficits following traumatic brain injury, J. Neurotrauma, 11, 187, 10.1089/neu.1994.11.187 · DOI · Paper page
- Angoa-Perez, M., Kane, M.J., Briggs, D.I., Francescutti, D.M., and Kuhn, D.M. (2013). Marble burying and nestlet shredding as tests of repetitive, compulsive-like behaviors in mice. J. Vis. Exp., 50978. · doi:10.3791/50978-v · Paper page
- Morgese, M.G., and Trabace, L. (2016). Maternal Malnutrition in the Etiopathogenesis of Psychiatric Diseases: Role of Polyunsaturated Fatty Acids. Brain Sci., 6. · DOI
- Agostoni, C., Nobile, M., Ciappolino, V., Delvecchio, G., Tesei, A., Turolo, S., Crippa, A., Mazzocchi, A., Altamura, C.A., and Brambilla, P. (2017). The Role of Omega-3 Fatty Acids in Developmental Psychopathology: A Systematic Review on Early Psychosis, Autism, and ADHD. Int. J. Mol. Sci., 18. · DOI
- Yui, 2012, Effects of large doses of arachidonic acid added to docosahexaenoic acid on social impairment in individuals with autism spectrum disorders: A double-blind, placebo-controlled, randomized trial, J. Clin. Psychopharmacol., 32, 200, 10.1097/JCP.0b013e3182485791 · DOI
- Bent, 2014, Internet-based, randomized, controlled trial of omega-3 fatty acids for hyperactivity in autism, J. Am. Acad. Child Adolesc. Psychiatry, 53, 658, 10.1016/j.jaac.2014.01.018 · DOI
- Voigt, 2014, Dietary docosahexaenoic acid supplementation in children with autism, J. Pediatr. Gastroenterol. Nutr., 58, 715, 10.1097/MPG.0000000000000260 · DOI
- Horvath, 2017, omega-3 Fatty Acid Supplementation Does Not Affect Autism Spectrum Disorder in Children: A Systematic Review and Meta-Analysis, J. Nutr., 147, 367, 10.3945/jn.116.242354 · DOI
- Cheng, 2017, Supplementation of omega 3 fatty acids may improve hyperactivity, lethargy, and stereotypy in children with autism spectrum disorders: A meta-analysis of randomized controlled trials, Neuropsychiatr. Dis. Treat., 13, 2531, 10.2147/NDT.S147305 · DOI
Cited by
Ornoy, A., Echefu, B., & Becker, M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms251910469 · Cited by 41
Self-citationThe sociability spectrum: evidence from reciprocal genetic copy number variations
López-Tobón, A., Trattaro, S., & Testa, G. (2020) · Molecular Autism · doi:10.1186/s13229-020-00347-0 · Cited by 20
Metadata
- Authors
- Ornoy, A., Weinstein-Fudim, L., & Ergaz, Z.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2019-03-01
- Volume
- 20
- Issue
- 5
- Pages
- 1074
- ISSN
- 1422-0067
- Cited by
- 47
- References
- 21
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.